Share This Page
Drug Price Trends for QC MOTION SICKNESS
✉ Email this page to a colleague
Average Pharmacy Cost for QC MOTION SICKNESS
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| QC MOTION SICKNESS 50 MG TAB | 83324-0032-12 | 0.06943 | EACH | 2024-12-18 |
| QC MOTION SICKNESS 50 MG TAB | 83324-0032-12 | 0.08295 | EACH | 2024-11-27 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
QC MOTION SICKNESS Market Analysis and Financial Projection
Motion Sickness Treatment Market Analysis and Projections
Market Overview
The motion sickness treatment market is experiencing significant growth, driven by increasing demand for efficient and high-quality medications. Here are the key points and projections for this market.
Market Size and Growth
The global motion sickness treatment market was valued at $393.70 million in 2021 and is projected to reach $525 million by 2031, growing at a CAGR of 2.9% from 2022 to 2031[1]. Another report indicates that the market size was $402.4 million in 2022 and is expected to reach $876.8 million by 2030, with a CAGR of 3.4% during the forecast period[3].
Segmentation by Drug Class
The market is segmented into antihistamines, anticholinergics, and others.
- Antihistamines: This segment dominated the market in terms of revenue in 2021 due to the high demand for antihistaminic medications, which are cost-effective and readily available[1][5].
- Anticholinergics: This segment is anticipated to grow at the fastest rate during the forecast period, with products like Transderm Scop (scopolamine transdermal patches) being highly recommended for motion sickness prevention[1].
Route of Administration
The market is classified into oral and other routes of administration.
- Oral: This segment dominated the market in 2021 due to the high demand for antihistaminic medications available in tablet, capsule, and pill forms[1].
- Others: This segment, which includes transdermal patches, is expected to grow at the fastest rate due to their convenience and extended efficacy. Transdermal patches offer therapeutic effects for up to 72 hours with a single patch, making them popular among travelers[1][5].
Distribution Channel
The market is segmented into hospital pharmacies, drug stores & retail pharmacies, and online pharmacies.
- Drug Stores & Retail Pharmacies: This segment exhibited the largest market share in 2021 due to the easy availability of over-the-counter (OTC) medications in these outlets[1].
- Online Pharmacies: This segment is anticipated to grow at the fastest rate due to the ease of accessibility and doorstep delivery services, making it convenient for patients to obtain the required medications quickly[1].
Regional Outlook
- North America: This region holds the highest market share and is expected to continue dominating the market due to its robust healthcare infrastructure and the presence of major market players[1][4][5].
- Asia-Pacific: This region is expected to witness the highest growth during the forecast period, driven by increasing investments in manufacturing high-quality products and the rising number of travelers[1][4].
Key Drivers and Trends
- Increasing Adoption of Prescription Drugs: The growing adoption of prescription drugs for motion sickness in developed economies is a major driver of the market[2][4].
- Rise in Tourism: The increase in the number of travelers globally, especially in regions like North America and Asia-Pacific, is driving the demand for motion sickness medications[1][4].
- Advancements in Manufacturing: The use of advanced technologies in the manufacturing of medications is enhancing product quality and contributing to market growth[1].
- Awareness and Prevention: Increased awareness about motion sickness and its treatment options is significantly contributing to the revenue generation in the market[1].
Impact of COVID-19
The COVID-19 pandemic had a significant impact on the motion sickness treatment market, particularly due to the reduction in international tourist arrivals. However, as travel restrictions are lifted and tourism resumes, the market is expected to expand and return to pre-pandemic levels in the coming years[4].
Key Players
Major players in the motion sickness treatment market include Perrigo Company, PLC, WellSpring Pharmaceutical Corporation, Myungmoon Pharm Co., Ltd., Reliefband Technologies LLC, and others such as Baxter, Prestige Consumer Healthcare Inc, and CVS Health[2][4].
Price Projections and Market Dynamics
Given the growth rate and market size projections, the prices of motion sickness treatments are likely to remain competitive due to the presence of both branded and generic medications.
- Antihistamines: These are expected to remain cost-effective and widely available, contributing to their dominant market share[1][5].
- Anticholinergics: Products like scopolamine transdermal patches may see a slight increase in price due to their advanced technology and convenience, but they are expected to remain in high demand[1].
Key Takeaways
- The motion sickness treatment market is growing at a CAGR of 2.9% to 3.4% during the forecast period.
- Antihistamines dominate the market, but anticholinergics are expected to grow at the fastest rate.
- Oral medications are prevalent, but transdermal patches are gaining popularity.
- North America holds the largest market share, with Asia-Pacific expected to witness the highest growth.
- The market is driven by increasing adoption of prescription drugs, rising tourism, and advancements in manufacturing.
FAQs
What is the current size of the motion sickness treatment market?
The motion sickness treatment market was valued at $393.70 million in 2021 and is expected to reach $525 million by 2031[1].
Which region dominates the motion sickness treatment market?
North America holds the highest market share in the motion sickness treatment market[1][4][5].
What are the key drivers of the motion sickness treatment market?
Key drivers include the increasing adoption of prescription drugs, rise in tourism, advancements in manufacturing, and increased awareness about motion sickness and its treatment options[1][2][4].
Which segment is expected to grow the fastest in terms of route of administration?
The "others" segment, which includes transdermal patches, is expected to grow at the fastest rate due to their convenience and extended efficacy[1][5].
Who are the major players in the motion sickness treatment market?
Major players include Perrigo Company, PLC, WellSpring Pharmaceutical Corporation, Myungmoon Pharm Co., Ltd., Reliefband Technologies LLC, and others such as Baxter, Prestige Consumer Healthcare Inc, and CVS Health[2][4].
Cited Sources:
- Allied Market Research - Motion Sickness Treatment Market Forecast| $5.3 Billion by 2031
- Transparency Market Research - Motion Sickness Treatment Market Analysis Report 2026
- IndustryARC - Motion Sickness Treatment Market - IndustryARC
- Mordor Intelligence - Motion Sickness Treatment Market - Trends & Size
- GlobeNewswire - Global $481 Million Motion Sickness Treatment Market, 2023-2029
More… ↓
